PDP1/PPAPDC2 Antibody Blocking Peptide

• Reactivity: Hu
• Applications: AC
• Concentration: 0.2 mg/ml

PDP1/PPAPDC2 Antibody Blocking Peptide Summary

• Description: A blocking peptide containing 13 amino acids near the carboxy terminus of human PPAPDC2.

  Source: Synthetic

  (Accession #: NP_982278)

• Source: Synthetic
• Protein/Peptide Type: Antibody Blocking Peptide
• Gene: PLPP6
• Purity: N/A

Applications/Dilutions

• Dilutions:
  • Antibody Competition
• Application Notes: This peptide is useful as a blocking peptide for NBP1-76245.
  
  For further blocking peptide related protocol, click here.

Packaging, Storage & Formulations

• Storage: Store at -20C. Avoid freeze-thaw cycles.
• Buffer: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
• Preservative: 0.02% Sodium Azide
• Concentration: 0.2 mg/ml
• Purity: N/A

Alternate Names for PDP1/PPAPDC2 Antibody Blocking Peptide

• bA6J24.6
• EC 3.1.3
• EC 3.1.3.-
• FLJ46512
• FLJ90191
• MGC15483
• PDP1
• phosphatidic acid phosphatase type 2 domain containing 2
• Phosphatidic acid phosphatase type 2 domain-containing protein 2
• polyisoprenoid diphosphate phosphatase type 1
• PPAP2 domain-containing protein 2
• presqualene diphosphate phosphatase
• PSDP

Background

Phosphatase that dephosphorylates presqualene diphosphate (PSDP) into presqualene monophosphate (PSMP),suggesting that it may be indirectly involved in innate immunity. PSDP is a bioactive lipid that rapidly remodels topresqualene monophosphate PSMP upon cell activation. Displays diphosphate phosphatase activity with a substratepreference for PSDP > FDP > phosphatidic acid

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.

Bioinformatics

• Gene Symbol: PLPP6